Text and Data Mining valid from 2019-03-19
Received: 9 November 2017
Accepted: 14 February 2019
First Online: 19 March 2019
: S.A.J. has received funding support from Hoffman-La Roche, GlaxoSmithKline, Ferring Pharmaceuticals and NovImmune SA and during the past 5 years has acted as an advisory consultant for Roche, Chugai Pharmaceuticals, NovImmune SA, Genentech, Sanofi Regeneron, Johnson & Johnson, Janssen Pharmaceuticals and Eleven Biotherapeutics.